Literature DB >> 19088178

Leukocyte trafficking in primary immunodeficiencies.

Luigi D Notarangelo1, Raffaele Badolato.   

Abstract

Leukocyte recirculation through central and peripheral lymphoid organs and peripheral tissues is essential to maintain immune homeostasis. Some of the genetically determined, primary immunodeficiencies compromise leukocyte trafficking. Here, we review the mechanisms and consequences of impaired leukocyte trafficking in leukocyte adhesion-deficiency syndromes, Warts-Hypo-gamma-globulinemia-Infections-Myelokathexis syndrome and Wiskott-Aldrich syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 19088178     DOI: 10.1189/jlb.0808474

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Leukocyte adhesion deficiency-I with a novel intronic mutation presenting with pyoderma gangrenosum- like lesions.

Authors:  Manisha Madkaikar; Khushnooma Italia; Maya Gupta; Mukesh Desai; Amita Aggarwal; Surjit Singh; Deepti Suri; Anju Mishra; Sushant Chavan; Kanjaksha Ghosh; Rishu Sarangal; Sunil Dogra
Journal:  J Clin Immunol       Date:  2015-04-16       Impact factor: 8.317

Review 2.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 3.  Interstitial leukocyte migration in vivo.

Authors:  Pui-ying Lam; Anna Huttenlocher
Journal:  Curr Opin Cell Biol       Date:  2013-06-21       Impact factor: 8.382

4.  Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia.

Authors:  Anne Sofie Andreasen; Theis Pedersen-Skovsgaard; Ronan M G Berg; Kira Dynnes Svendsen; Bo Feldt-Rasmussen; Bente K Pedersen; Kirsten Møller
Journal:  Intensive Care Med       Date:  2010-03-13       Impact factor: 17.440

Review 5.  The role of neutrophils in host defense and disease.

Authors:  Heather K Lehman; Brahm H Segal
Journal:  J Allergy Clin Immunol       Date:  2020-04-10       Impact factor: 14.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.